PAHC
NASDAQ · Pharmaceuticals
Phibro Animal Health Corp-A
$34.56
+0.12 (+0.33%)
Financial Highlights (FY 2026)
Revenue
1.48B
Net Income
96.98M
Gross Margin
33.3%
Profit Margin
6.6%
Rev Growth
+15.8%
D/E Ratio
1.90
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 33.3% | 33.3% | 36.7% | 36.7% |
| Operating Margin | 12.8% | 11.5% | 35.4% | 32.2% |
| Profit Margin | 6.6% | 6.2% | 25.7% | 26.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 1.48B | 1.28B | 1.31B | 972.76M |
| Gross Profit | 492.07M | 424.97M | 479.67M | 357.06M |
| Operating Income | 189.12M | 147.00M | 462.06M | 312.99M |
| Net Income | 96.98M | 75.38M | 335.32M | 253.19M |
| Gross Margin | 33.3% | 33.3% | 36.7% | 36.7% |
| Operating Margin | 12.8% | 11.5% | 35.4% | 32.2% |
| Profit Margin | 6.6% | 6.2% | 25.7% | 26.0% |
| Rev Growth | +15.8% | +15.8% | +2.9% | -6.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 464.94M | 464.94M | 399.08M | 413.63M |
| Total Equity | 244.58M | 244.58M | 1.04B | 1.11B |
| D/E Ratio | 1.90 | 1.90 | 0.38 | 0.37 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 239.15M | 196.21M | 482.41M | 394.81M |
| Free Cash Flow | — | — | 282.39M | 183.99M |